跳至主要内容
临床试验/EUCTR2016-001528-69-IE
EUCTR2016-001528-69-IE进行中(未招募)1 期

PENICILLIN FOR THE EMERGENCY DEPARTMENT-DIRECTED OUTPATIENT TREATMENT OF CELLULITIS (PEDOCELL) STUDY: A NON-INFERIORITY ADAPTIVE RANDOMISED CONTROLLED TRIAL.

Royal College of Surgeons in Ireland0 个研究点目标入组 50 人开始时间: 2016年8月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Clinically diagnosed cellulitis, wound infection & abscess affecting any body part, excluding the perineum, and having any two of the following signs:
  • Tenderness / Pain of affected area
  • Oedema / Induration
  • Regional lymphadenopathy
  • Purulent drainage
  • 2.Cellulitis, wound infection & abscess deemed treatable with oral antibiotics on an outpatient basis
  • 3.Patients with cellulitis, wound infection & abscess who have no signs of systemic toxicity and have no uncontrolled co-morbidities.
  • 4.Written informed consent obtained.
  • 5.16 years of age or older.
  • 6.Fluency in written and spoken English.
  • 7.Willing to return for study follow-up or to have the research nurse or clinical project coordinator visit them.
  • 8.Willing to receive a telephone call from a study investigator.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 50
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • 1.Penicillin allergy (self-reported or confirmed).
  • 2.Any cellulitis wound infection & abscess that treating clinicians deem treatable with intravenous (IV) antibiotics.
  • 3.Patients that may have a significant systemic upset such as acute confusion, tachycardia, tachypnoea, hypotension or may have unstable co-morbidities that may interfere with a response to therapy or have a limb threatening infection due to vascular compromise.
  • 4.Patients who may have a severe life threatening infection such as necrotizing fasciitis.
  • 5.Any cellulitis wound infection & abscess of the perineal region.
  • 6.Patients who have received more than 24 hours of effective antibiotics for the current episode of acute cellulitis, wound infection & abscess
  • 7.Any medical condition, based on clinical judgment that may interfere with the interpretation of the primary outcome measures (e.g. a chronic skin condition at the site of the cellulitis wound infection or abscess).
  • 8.Immunodeficiency from primary or secondary causes (e.g. corticosteroids, chemotherapeutic agents).
  • 9.Previous history of renal dysfunction or known chronic kidney disease under the care of a nephrologist. ?
  • 10.Previous history of liver dysfunction defined as chronically deranged liver function tests elicited from the medical notes or history.
  • 11.Suspected or confirmed septic arthritis.
  • 12.Suspected or confirmed osteomyelitis.
  • 13.Infection involving prosthetic material.
  • 14.Pregnant or lactating women.
  • 15.Patients with a previous history of flucloxacillin-associated jaundice/hepatic dysfunction
  • 16.Patients with a previous history of methicillin-resistant staphylococcus aureus (MRSA) colonisation/infection.
  • 17.Patients with lactose intolerance diagnosed by a medical professional.
  • 18.Patients currently taking probenecid, neomycin, chloramphenicol, erythromycin , tetracyclines sulfinpyrazone, methotrexate, guar gum or an oral anticoagulant.

研究者

相似试验